PHARMA MAR, S.A. «...1617181920...» Page 20 out of 22 17/06/2020 17:35 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 10 June and 16 June 2020. Register number: 2831 10/06/2020 17:36 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 3 June and 9 June 2020. Register number: 2694 08/06/2020 17:39 PHARMA MAR, S.A. Announcement of general shareholders’ meeting The Company publishes a supplementary announcement regarding the call to the Annual General Shareholders’ Meeting Register number: 2610 03/06/2020 17:47 PHARMA MAR, S.A. Other relevant information The Company reports that will host a virtual Key Opinion Leader (KOL) event on lurbinectedin and Small Cell Lung Cancer (SCLC) on June 10th, 2020, at 20.00 CET Register number: 2554 03/06/2020 17:41 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 27 May and 2 June 2020. Register number: 2553 03/06/2020 08:29 PHARMA MAR, S.A. On business and financial situation The Company announces that the Therapeutic Goods Administration (TGA) has granted the “Provisional Approval Pathway” for lurbinectedin in relapsed Small Cell Lung Cancer in Australia. Register number: 2543 27/05/2020 17:38 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 20 May and 26 May 2020. Register number: 2453 20/05/2020 17:35 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 13 May and 19 May 2020. Register number: 2324 14/05/2020 20:09 PHARMA MAR, S.A. Announcement of general shareholders’ meeting The communication with registration number 2256 is rectified by attaching the announcement of the General Meeting of Pharma Mar, S.A. Register number: 2264 Notification modified by communication number 2256 dated 14/05/2020 (18:10) 14/05/2020 18:10 PHARMA MAR, S.A. Announcement of general shareholders’ meeting The Company sends notice of call, proposed resolutions and Directors´ Compensation Policy for 2020-2022 in relation to item Eight of the Agenda of the General Shareholders´ Meeting of Pharma Mar, S.A. Register number: 2256 Notification modified by communication number 2264 dated 14/05/2020 (20:09) Page 20 out of 22 «...1617181920...»
